Weight Loss Injections in Abu Dhabi
Diet and exercise are the foundation of any weight loss plan. But for many people, they are not enough on their own. Genetics, hormonal factors, and metabolic conditions can make losing weight and sustaining that loss genuinely difficult, regardless of effort. Weight loss injections in Abu Dhabi offer a clinically approved, medically supervised addition to a structured weight management plan, working with the body's own appetite and metabolic signals to support meaningful, sustained weight reduction.
Quick Facts
| Treatment Type | Prescription injectable weight management medication |
| Mechanism | GLP-1 receptor agonists (and dual GLP-1/GIP for Mounjaro) |
| Available Injectables | Saxenda, Wegovy, Ozempic, Mounjaro |
| Injection Frequency | Daily (Saxenda) or weekly (Wegovy, Ozempic, Mounjaro) |
| Session Duration | Under 30 minutes per administration visit |
| Prescription Required | Yes, all injectables require a medical assessment and prescription |
| Best Results | When combined with a calorie-controlled diet and regular activity |
| Side Effects | Mild to moderate; most resolve as the body adjusts |
| Starting Cost | 1,800 AED |
What Are Weight Loss Injections?
Weight loss injections are prescription-only medications that support clinically supervised weight management by targeting the hormonal and neurological pathways that regulate appetite, satiety, and blood sugar.
The most widely used injectables belong to a class called GLP-1 receptor agonists. GLP-1 (glucagon-like peptide-1) is a hormone naturally released by the gut after eating. It signals the brain to reduce hunger, slows the rate at which the stomach empties, and helps regulate blood glucose. GLP-1 receptor agonist medications mimic and amplify this signal, producing sustained reductions in appetite and calorie intake that support progressive weight loss.
These are not aesthetic fat-dissolving treatments. They work systemically through the body's hormonal system and are most effective as part of a medically supervised programme that includes dietary guidance and lifestyle support.
Cost of Weight Loss Injections in Abu Dhabi
The following are indicative price ranges for each injectable available at our clinic. Costs vary by dosage tier and individual treatment duration.
| Injection Type | Cost in AED |
|---|---|
| Saxenda (Liraglutide) | 1,800 to 2,650 |
| Wegovy (Semaglutide 0.5 mg) | 2,300 to 2,500 |
| Wegovy (Semaglutide 1 mg) | 2,400 to 2,700 |
| Mounjaro (Tirzepatide 2.5 mg) | 2,900 to 3,000 |
| Mounjaro (Tirzepatide 5 mg) | 2,900 to 3,500 |
| Ozempic (Semaglutide 0.5 mg) | 2,000 to 2,300 |
| Ozempic (Semaglutide 1 mg) | 2,200 to 2,500 |
Final pricing is confirmed at consultation after your physician has assessed the most appropriate medication and starting dosage for your profile. All costs are confirmed before any treatment begins.
Weight Loss Injectables Available at Our Clinic
Saxenda (Liraglutide)
Saxenda contains liraglutide, a GLP-1 receptor agonist administered as a daily subcutaneous injection. It reduces hunger by acting on appetite-regulating centres in the brain, slowing gastric emptying and producing a prolonged sense of fullness after meals.
Saxenda is approved for adults with a BMI of 30 or above, or 27 and above with at least one weight-related health condition. It is also approved for adolescents aged 12 and above meeting specific criteria. The dose is started low and increased gradually over several weeks to minimize gastrointestinal side effects.
Wegovy (Semaglutide)
Wegovy contains semaglutide at doses specifically developed and approved for chronic weight management. It is administered once weekly, which many patients find more manageable than daily injections.
Wegovy activates GLP-1 receptors in the brain's appetite-regulating region, significantly reducing hunger signals and prolonging the sensation of fullness. Clinical trials demonstrated average weight loss of approximately 15% of body weight over 68 weeks in patients using Wegovy alongside lifestyle intervention. It is approved for adults with a BMI of 30 or above, or 27 and above with a weight-related comorbidity.
Mounjaro (Tirzepatide)
Mounjaro is the most advanced injectable in this category. It is a dual agonist acting on both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously, a mechanism no other approved weight loss injectable currently shares.
GIP is a second gut hormone involved in energy storage and metabolic regulation. By targeting both receptors together, Mounjaro produces a more pronounced effect on appetite suppression, blood sugar regulation, and fat metabolism than single-receptor GLP-1 medications. Clinical data show average weight loss of up to 20% of body weight in some patient groups. It is indicated for adults with obesity or overweight with comorbidities, and for adults with type 2 diabetes.
Ozempic (Semaglutide)
Ozempic contains semaglutide and was originally developed and approved as a treatment for type 2 diabetes. It is now widely used off-label for weight management in patients who do not have diabetes, given its significant appetite-suppressing and weight-reducing effects.
Ozempic is administered once weekly. Available doses for weight management are typically 0.5 mg and 1 mg. It reduces appetite, slows gastric emptying, and helps stabilize blood glucose. Patients using Ozempic for weight management should do so under medical supervision with regular monitoring, as it remains primarily a diabetes medication.
Who Is the Right Candidate?
Weight loss injections are appropriate for adults who meet the following criteria:
- You have a BMI of 30 or above (obesity), or a BMI of 27 or above with at least one weight-related health condition such as type 2 diabetes, hypertension, or dyslipidemia
- You have attempted weight loss through diet and exercise without achieving or sustaining sufficient results
- You are committed to combining the injectable treatment with dietary changes and increased physical activity for the best outcomes
- You are in good general health with no contraindications to GLP-1 receptor agonist medications
- You are not pregnant or planning to become pregnant during the course of treatment
- You have realistic expectations. These medications support weight loss progressively over months; they are not rapid fat-removal treatments
Contraindications include:
- Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- History of pancreatitis
- Severe gastrointestinal disorders
- Pregnancy or breastfeeding
- Known hypersensitivity to the active ingredient
A full medical assessment is conducted before any injectable is prescribed. These medications are not available without a clinical consultation and a valid prescription.
How to Prepare for Your Session
- Attend your initial medical consultation so your physician can assess your suitability, review your medical history, and prescribe the appropriate medication and starting dose
- Disclose all current medications, supplements, and relevant medical history; several medications interact with GLP-1 agonists
- Begin or maintain a calorie-appropriate diet and activity plan as advised by your physician before starting injections
- Arrive at each administration session with a clean, accessible injection site (typically the abdomen, thigh, or upper arm)
- Stay well-hydrated and avoid alcohol in the 24 hours before each session
Procedure: How Weight Loss Injections Are Administered
Medical Assessment and Prescription
Your physician conducts a full clinical assessment, including weight, BMI, relevant blood markers, and a medical history review. The most appropriate injectable and starting dose are selected and prescribed based on your individual profile.
Preparation of the Injection Site
The selected injection site is cleaned with an alcohol swab and allowed to dry. The appropriate dose is confirmed and prepared.
Subcutaneous Injection
The medication is administered as a subcutaneous injection into the fatty tissue just beneath the skin of the abdomen, thigh, or upper arm using the pre-filled pen device. The injection itself takes only a few seconds.
Post-Injection Observation
The injection site is checked. You remain at the clinic briefly to confirm there is no immediate adverse reaction. The pen device is disposed of safely. Your physician reviews progress, adjusts dosage if indicated, and schedules the next session.
Ongoing Monitoring
Follow-up appointments track your weight, response to the medication, side effects, and overall health markers. Dose escalation follows a structured protocol, gradually increasing to the therapeutic dose over several weeks to minimize gastrointestinal side effects.
Results: What to Expect
Results from weight loss injections vary based on the medication used, the dosage achieved, the degree of dietary and lifestyle adherence, and individual metabolic factors.
| Timeframe | What to Expect |
|---|---|
| Weeks 1 to 4 | Appetite reduction begins; initial weight loss of 1 to 2 kg as the dose is titrated upward |
| Months 2 to 3 | More consistent appetite suppression at therapeutic dose; steady weight loss typically established |
| Months 3 to 6 | Meaningful weight loss visible; energy levels and metabolic markers often begin to improve |
| Months 6 to 12 | Continued progressive weight loss for most patients; plateau possible in some cases, requiring dose review |
| Beyond 12 months | Long-term results depend on maintaining the medication alongside lifestyle modifications |
Clinical data from phase 3 trials show average weight loss of 5 to 7% of body weight with Saxenda, 12 to 15% with Wegovy, and up to 20% with Mounjaro over 12 to 18 months. Individual results vary.
Benefits of Weight Loss Injections
- Clinically approved and medically supervised approach to weight management
- Addresses the hormonal drivers of hunger and appetite that willpower alone cannot override
- Reduces food cravings and prolongs satiety between meals
- Supports sustained weight loss over months rather than a rapid, unsustainable short-term reduction
- Weekly injection options available, no daily commitment required
- Positive secondary effects on blood sugar regulation, blood pressure, and cardiovascular risk markers in many patients
- Can be combined with dietary counselling and activity plans for optimal outcomes
- Reversible medication can be discontinued at any point under physician guidance
Why Choose Us for Weight Loss Injections in Abu Dhabi?
Medical weight management requires clinical oversight, not just product dispensing. Our approach combines proper assessment, prescription accuracy, ongoing monitoring, and lifestyle support into a structured programme.
- Certified physicians and healthcare professionals specializing in weight management and metabolic health
- Full medical assessment at consultation, no prescriptions issued without clinical evaluation
- Personalized treatment plans accounting for your BMI, medical history, current medications, and metabolic profile
- Structured dose titration protocol to minimize side effects during the adjustment period
- Regular monitoring appointments to track progress and adjust the plan as needed
- Transparent, itemized pricing confirmed before any treatment begins
Book Your Consultation in Abu Dhabi
If you want to explore medically supervised weight loss injections, a clinical consultation is the mandatory first step. Your physician will assess your suitability, recommend the most appropriate medication, and build a structured programme with realistic weight loss targets.
Book online, call us directly, or visit our clinic in Abu Dhabi to get started.
